Gelion (GELN): Results ahead of expectations
This situation live
GELN Gelion
21 Oct 2026 · ahead of expectations · second in 12 months · −12% since
These partnerships, together with the milestones achieved across our technology programmes, demonstrate the progress we have made in positioning Gelion's technologies for commercial deployment.
Results ahead of expectations
ahead of expectations · second in 12 months
Directionahead of expectations / raised
Reaction on the day+31%
In 12 months2 statements in the same direction
Company's wordsThese partnerships, together with the milestones achieved across our technology programmes, demonstrate the progress we have made in positioning Gelion's technologies for commercial deployment. ↗
As of 21 Oct 2026 ↗
Since Oct 2023: 1145 situations of this kind; median share price +0% six months after they opened
Every step · 1
- 21 Oct 2026 ahead of expectations · second in 12 months – These partnerships, together with the milestones achieved across our technology programmes, demonstrate the progress we have made in positioning Gelion's... ↗
What is happening
Gelion: Results ahead of expectations – ahead of expectations · second in 12 months. ['ahead of expectations · second in 12 months']
- In short
- Gelion said it is trading ahead of expectations on 21 Oct 2026; the shares moved +31% on the day. It is the second such statement in 12 months.
- Announced
- 21 Oct 2026 · ahead of expectations · +31% on the day
From the company's own announcements. Not investment advice.
Briefing Pro
New to Gelion? Get up to speed in 2 minutes.
What it does, how it got here, what management promised and delivered – written from its own announcements.
Get the GELN briefing →Also at Gelion 3 open
Project milestonesMitsui Kinzoku sulfur battery JDA – Agreement signed 13 Oct 2026; OEM funding amount undisclosed
New CEO / resetNew CEO and commercial scale-up – New CEO in place; newsletter reiterates scale-up focus
Project milestonesTDK sulfur battery collaboration – Testing being expanded after early pouch cells
Upgrade / downgrade cycleResults ahead of expectations – ahead of expectations · closed
Insider conviction1 director buying – £30k in 1 buy · closed
Gelion – company page →